Hana Kostrhunová

19PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metal organic frameworksPolymerisation mechanismsSupramolecular chemistryHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Nov 10, 2025
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.

Sofia Sharkawy, Sourav Acharya, Hana Kostrhunová

|Dec 02, 2024
A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent.

Alicia Marco, Jana Kasparkova, Delia Bautista

|Oct 21, 2024
Ni(II) Cylinders Damage DNA in Cancer Cells and Preferentially Bind Y-Shaped DNA Three-Way Junctions Blocking DNA Synthesis.

Jaroslav Malina, Hana Kostrhunova, Viktor Brabec

|Jul 19, 2024
Dicobalt(ii) helices kill colon cancer cells via enantiomer-specific mechanisms; DNA damage or microtubule disruption.

Hualong Song, Hana Kostrhunova, Jakub Cervinka

|Aug 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.

Amrita Sarkar, Vojtech Novohradsky, Moumita Maji

|Aug 25, 2023
The mechanism of antiproliferative activity of the oxaliplatin pyrophosphate derivative involves its binding to nuclear DNA in cancer cells.

Jitka Prachařová, Hana Kostrhunová, Alessandra Barbanente

Pageof 4

Frequent Collaborators

19 joint publications

Viktor Brabec

10 joint publications

Jana Kasparkova

7 joint publications

Lenka Markova

7 joint publications

Vojtech Novohradsky